CASE REPORT
Recurrent paralytic ileus associated with strongyloidiasis in a patient with systemic lupus erythematosus
Authors
Hide Yoshida1 , Hirahito Endo1, Sumiaki Tanaka1, Akira Ishikawa1, Hirobumi Kondo1 and Takeshi Nakamura2
| (1) |
Division of Rheumatology, Department of Internal Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara 228-8555, Japan |
| (2) |
Department of Microbiology and Parasitology, Kitasato University School of Medicine, Sagamihara, Japan |
Received:
07 October 2005
Accepted:
22 November 2005
Full Text
> Click Here （member's only）
Abstract
We present an interesting case of recurrent paralytic ileus due to strongyloidiasis in a woman who was being treated with corticosteroids and immunosuppressants for systemic lupus erythematosus (SLE). She was also a carrier of human T-cell leukemia virus type I. She had a history of strongyloidiasis 8 years earlier. Recurrent episodes of paralytic ileus due to strongyloidiasis occurred during treatment of her SLE with corticosteroids. Ivermectin was given and improved the symptoms. This case shows that symptomatic strongyloidiasis can be induced in immunocompromised hosts by immunosuppressive therapy. It is important to rule out strongyloidiasis prior to starting immunosuppressive therapy in patients from endemic areas.
Key words
Corticosteroids - Cyclophosphamide - Human T-cell leukemia virus type I (HTLV-I) - Paralytic ileus - Strongyloidiasis - Systemic lupus erythematosus (SLE)
The references of this article are secured to subscribers. |
